{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:28:48Z","timestamp":1784640528106,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013595","name":"AMAG Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["3R21HD101127-01S1"],"award-info":[{"award-number":["3R21HD101127-01S1"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["24-FY20-58"],"award-info":[{"award-number":["24-FY20-58"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ajog.2023.12.028","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T16:16:40Z","timestamp":1703348200000},"page":"344.e1-344.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Aspirin pharmacokinetics and pharmacodynamics through gestation"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-6943","authenticated-orcid":false,"given":"Rupsa C.","family":"Boelig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Rochani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.12.028_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0040-1718580","article-title":"Improving utilization of aspirin for prevention of preeclampsia in a high-risk urban cohort: a prospective cohort study","volume":"38","author":"Boelig","year":"2021","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.12.028_bib2","doi-asserted-by":"crossref","first-page":"419.e1","DOI":"10.1016\/j.ajog.2020.03.004","article-title":"Impact of the ACOG guideline regarding low-dose aspirin\u00a0for prevention of superimposed preeclampsia in women with chronic hypertension","volume":"223","author":"Banala","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.028_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on\u00a0the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.028_bib4","series-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality","author":"Henderson","year":"2021"},{"key":"10.1016\/j.ajog.2023.12.028_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A\u00a0pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.028_bib6","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1016\/j.ajog.2022.11.407","article-title":"Individual predictors of platelet\u00a0response to aspirin therapy in pregnancy","volume":"228","author":"Boelig","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.028_bib7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.12.028_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.12.028_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring\u00a0of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2023.12.028_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/jcpt.12643","article-title":"PFA-100-measured aspirin resistance is the predominant risk factor for hospitalized cardiovascular events in aspirin-treated patients: a 5-year cohort study","volume":"43","author":"Chen","year":"2018","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.ajog.2023.12.028_bib11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V104.11.1859.1859","article-title":"Patients with coronary artery disease have an increased incidence of aspirin resistance: association of PFA-100 closure time with clinical findings","volume":"104","author":"Frelinger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2023.12.028_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2023.12.028_bib13","doi-asserted-by":"crossref","first-page":"285S","DOI":"10.1111\/j.1365-2125.1980.tb01811.x","article-title":"Clinical pharmacokinetics of salicylates: a re-assessment","volume":"10","author":"Levy","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2023.12.028_bib14","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and\u00a0laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.028_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cpt.382","article-title":"Pregnancy-related pharmacokinetic changes","volume":"100","author":"Tasnif","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2023.12.028_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1538-7836.2008.02897.x","article-title":"Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis","volume":"6","author":"Reny","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajog.2023.12.028_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283163","article-title":"Aspirin modulates production of pro-inflammatory and pro-resolving mediators in\u00a0endothelial cells","volume":"18","author":"Rood","year":"2023","journal-title":"PLoS One"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782302183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782302183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T12:41:34Z","timestamp":1724330494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293782302183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S000293782302183X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.12.028","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin pharmacokinetics and pharmacodynamics through gestation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}